Label Free Detection Market

Label Free Detection Market by Product & Service (Instruments, Consumables (Biosensor Chips, Microplates), Software), Technology (Surface Plasmon Resonance), Application (Hit Confirmation, Lead Generation), End User (Pharma, CROs) & Region Global Forecast to 2028

Report Code: BT 2455 Jul, 2023, by marketsandmarkets.com

The global label free detection market in terms of revenue was estimated to be worth $570 million in 2023 and is poised to reach $863 million by 2028, growing at a CAGR of 8.7% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The growth of this market is majorly driven by the technological advancements in label-free detection market, growing number academic-industrial partnerships for drug discovery programs and high sensitivity of label-free technologies. On the other hand, high cost of instruments is a major factor restraining market growth to a certain extent.

Attractive Opportunities in Label-Free Detection Market

Label-Free Detection Market

To know about the assumptions considered for the study, Request for Free Sample Report

Label-Free Detection Market

Label Free Detection Market Dynamics

DRIVER: Technological advancements in label-free detection

Label-free methods are a relatively new technology in high-throughput screening and provide opportunities for investigating biomolecular interactions without using spatial interference or the auto-fluorescent or quenching effects of labels. Initially, low throughput was a challenge associated with label-free technologies. However, the introduction of SPR-based label-free systems with higher throughput has helped increase overall operational efficiency while providing the high-quality data needed to make informed decisions. For instance, in September 2021, TA Instrument Systems, a subsidiary of Waters Corporation, introduced the TMA 450RH and the Discovery SA. The TMA 450RH provides measurements of dimensional compatibility of materials under controlled temperature and humidity. The Discovery SA is used in pharmaceutical development to assess the impact of moisture in drug product processing and storage on crystalline structure, which is related to drug product efficacy.

RESTRAINT: High cost of instruments

Label-free detection instruments are priced at a premium due to their incorporation of advanced features and functionalities. For instance, a typical bio-layer interferometry system can cost anywhere between USD 50,000 to USD 300,000. Agilent's xCELLigence systems, available for academic and industrial use, fall within the price range of USD 50,000 to USD 500,000, depending on options like throughput. This puts these instruments out of reach for companies with limited R&D budgets, impeding market expansion. Academic research laboratories also face difficulties investing in such instruments due to financial constraints. Moreover, the high initial and ongoing costs, along with weekly maintenance expenses, associated with surface plasmon resonance (SPR) systems, confine label-free platforms to well-funded labs and academic core labs. The complexity of SPR platforms further renders them unsuitable for multi-user laboratories. On the other hand, pharmaceutical companies, with larger R&D budgets, represent the primary users of label-free detection instruments. However, their need for multiple instruments increases their capital expenditure. Consequently, the high cost of these instruments may curtail demand and limit overall market growth.

OPPORTUNITY: Growing life sciences research in emerging economies

The label-free detection market in Asia is experiencing significant growth, primarily propelled by the expanding economies of China and India, as well as increased investments in biotechnology and drug discovery. While most Asian countries currently lack established business models, they possess the scientific expertise necessary to foster robust local biotechnology industries. As a result, there is a growing trend of mergers, collaborations, and partnerships in these emerging countries. Many Asian economies have also modified to their regulations, policies, and guidelines to encourage investments, innovation, and commercialization, leading to a rise in research activities within the life science industry.

Over the years, China’s pharma industry has shifted from primarily focusing on manufacturing generics and copy-cat drugs to research & development of innovative treatments. Many pharma and biopharmaceutical companies, such as Lonza, AstraZeneca, GlaxoSmithKline, Sanofi, and Ferring Pharmaceuticals, have announced plans to invest in life science R&D activities in emerging markets in the coming years. These increasing investments will further boost R&D activities, which, in turn, will provide a range of growth opportunities for players in the market. For instance, in March 2022, Lonza AG, a pharmaceutical company, announced the completion of a laboratory expansion at its API manufacturing site in Nansha, China. The expansion focused on extending the capabilities and capacity of development laboratories and kilogram-scale cGMP manufacturing laboratories for the clinical supply of highly potent APIs (HPAPIs).

CHALLENGE: Sample complexity and interference

Many samples of interest, especially in biological and environmental sciences, are complex heterogenous mixtures containing multiple analytes, macromolecules, cells, or particles. Analyzing such mixtures with label-free techniques can be challenging due to their diverse components, varying concentrations, and potential interactions. The sample matrix, which refers to the composition and characteristics of the surrounding medium or biological fluid, can significantly influence label-free technologies such as SPR and DSC performance and accuracy. Interactions between the analyte of interest and the matrix components can lead to changes in signal intensity, nonspecific binding, or altered kinetics, affecting the accuracy and specificity of the analysis.

Additionally, background noise from impurities, scattering particles, or variations in the sample matrix can mask or interfere with the signals of interest, reducing the signal-to-noise ratio and affecting the detection sensitivity. Furthermore, nonspecific binding, cross-reactivity, and masking effects can affect the sensitivity and specificity of the measurements, leading to difficulties in data analysis and interpretation. It requires a comprehensive understanding of the sample characteristics, careful experimental design, optimization of sample preparation methods, selective surface modifications, reference and control experiments, advanced data analysis techniques, and validation & comparative studies to address the sample complexity and interference challenges. By addressing these challenges, label-free technologies can provide valuable insights into complex samples and enable accurate analysis in diverse research and application fields.

Label-free Detection Market Ecosystem

The label-free detection market is a complex ecosystem involving various stakeholders, including supply side i.e companies providing label-free detection products & services and demand side i.e.  pharmaceutical & biotechnology companies, academic & research institutes, contract research organization and other end users such as food & beverages industry, agriculture and livestock, oil & gas industry, environmental monitoring industry, chemical industry, bioplastics, and Cosmeceuticals industries.

Several key companies provide products for label-free detection. For example, Danaher (US) is a leading provider of scientific products, including a range of solutions for label-free detection. They offer a comprehensive portfolio of instruments, consumables, and software & services. Their products, such as Biacore series of SPR instruments, consumables, and software, are widely used in the biotechnology industry. Other products providers include Sartorius AG (Germany), Waters Corporation (US), PerkinElmer Inc. (US), Ametek, Inc. (US), and others.

Label-Free Detection Market Ecosystem

The instruments segment dominated label free detection industry by product & service:

The instruments segment held the largest share of the global label free detection market in 2022. The drug discovery industry is adopting label-free technologies for various molecular and cellular assays since it has become vital for drug discovery labs to identify lead failure earlier because of safety concerns. This creates demand for automated and easy-to-use bioanalytical systems, which is driving the growth of instrument segment. Furthermore, with the help of enhanced instrumentation, pharmaceutical and biotechnology companies can streamline and simplify laboratory workflows to improve productivity and reduce costs. Both biomolecular interactions and whole cells can be assayed using a variety of label-free instruments available today. Recent advances in label-free instruments offer improved costs, throughput, increased sensitivity, and sophisticated data analysis.

The binding kinetics segment dominated label free detection industry by application

The binding kinetics segment held the largest share of the global label free detection market in 2022. Growth in this segment is mainly driven by factors such as the increasing number of drug discovery research and development activities and increasing efforts to study biomolecular kinetics through label-free detection technologies. Binding kinetic studies measure drug residence time, which is important for predicting clinical outcomes of drugs. Binding kinetics help in understanding how fast a compound binds to its target and how fast it dissociates from it. It measures two things, the on-rate, and the off-rate. Measuring the on- and off-rate used to be a lengthy process. Modern biophysical techniques like SPR enable the direct measurement of on- and off-rates without using labels. SPR is the standard technique routinely used in laboratories for characterizing the affinity and kinetics of drugs binding to target proteins in vitro. It is applicable for a wide range of protein classes, particularly soluble proteins, including enzymes, kinases, and proteases. BLI is another alternative for profiling binding kinetics, mostly for antibodies.

Asia Pacific region of the label free detection industry is estimated to register the highest CAGR during the forecast period.

Asia Pacific offers lucrative growth potential for the label free detection market. This can be attributed to the increasing pharmaceutical R&D spending, the growing trend of outsourcing drug discovery services, growing life sciences research, and increasing government initiatives for healthcare research. One significant growth driver for the label-free detection market in the Asia Pacific region is the increasing investment in healthcare infrastructure and research & development (R&D) activities. Governments and private entities are allocating substantial funds and launching various research programs to enhance healthcare facilities and promote scientific advancements, including label-free detection technologies.

The Asia-Pacific Economic Cooperation (APEC) Life Sciences Innovation Forum (LSIF) and its Regulatory Harmonization Steering Committee (RHSC) adopted a strategic plan (Vision 2020: A Strategic Framework: Regulatory Convergence for Medical Products by 2020). This strategic plan provided the basic proposal and rationale for achieving regional regulatory convergence of medical product approval procedure. The forum’s vision is to accelerate regulatory convergence for medical products in the APEC region as much as possible by 2030 to protect people’s safety, make life-saving products available, save public resources, attract investments, mitigate corruption, and improve global standing in every APEC economy. Thus, favourable regulatory guidelines for product approval is expected to drive the market growth.

Label-Free Detection Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Key players in the label free detection market include Danaher (US), Sartorius AG (Germany), Waters Corporation (US), PerkinElmer, Inc. (US), AMETEK, Inc. (US), HORIBA, Ltd. (Japan), Spectris (UK), METTLER TOLEDO International Inc., (US), Agilent Technologies, Inc. (US), Shimadzu Corporation (Japan), Hitachi High-Tech Corporation (Japan), Attana AB (Sweden), Bruker (US), NanoTemper Technologies GmbH (Germany), Affinité Instruments (Canada), Biosensing Instrument (US), Unchained Labs (US), BioNavis Ltd. (Finland), Carterra, Inc. (US), Nicoya (Canada), BiOptix Analytical LLC (US), Plexera Bioscience (US), XanTec Bioanalytics GmbH (Germany), lino Biotech AG (Switzerland), and KEP Technologies (France).

Scope of the Label Free Detection Industry

Report Metric 

Details 

Market Revenue in 2023

$570 million

Projected Revenue by 2028

$863 million

Revenue Rate

Poised to Grow at a CAGR of 8.7%

Market Driver

Technological advancements in label-free detection

Market Opportunity

Growing life sciences research in emerging economies

This report categorizes the label free detection market to forecast revenue and analyze trends in each of the following submarkets:

By Product & Service

  • Instruments
  • Consumables
    • Biosensor Chips
    • Microplates
    • Reagents & Kits
  • Software and Service

By Technology

  • Surface Plasmon Resonance
  • Bio-Layer Interferometry
  • Isothermal Titration Calorimetry
  • Differential Scanning Calorimetry
  • Other Technologies

By Application

  • Binding Kinetics
  • Binding Thermodynamics
  • HIT Confirmation
  • Lead Generation
  • Endogenous Receptor Detection
  • Other Applications

By End User

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organization
  • Other End Users

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific (APAC)
    • China
    • Japan
    • India
    • Rest of Asia Pacific (RoAPAC)
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

Recent Developments of Label Free Detection Industry

  • In April 2022, Sartorius launched the new Octet SF3, the first SPR system under the Sartorius Octet brand. Octet SF3 is a next-generation SPR instrument that offers robust, high-throughput, low maintenance characterization of biomolecular interactions.
  • In February 2021, Creoptix, a subsidiary of Malvern Panalytical, launched WaveRAPID, a new and faster way of measuring kinetics to accelerate drug discovery.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 32)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE 
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED
           1.3.3 CURRENCY CONSIDERED
    1.4 LIMITATIONS 
    1.5 STAKEHOLDERS 
    1.6 SUMMARY OF CHANGES 
           1.6.1 RECESSION IMPACT
 
2 RESEARCH METHODOLOGY (Page No. - 37)
    2.1 RESEARCH DATA 
          FIGURE 1 LABEL-FREE DETECTION MARKET: RESEARCH DESIGN
           2.1.1 SECONDARY RESEARCH
           2.1.2 PRIMARY RESEARCH
                    FIGURE 2 LABEL-FREE DETECTION MARKET: BREAKDOWN OF PRIMARIES
    2.2 MARKET SIZE ESTIMATION 
          FIGURE 3 LABEL-FREE DETECTION MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2022
          FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1—REVENUE SHARE ANALYSIS (2022)
          5 KEY INDUSTRY INSIGHTS
    2.3 GROWTH FORECAST 
          FIGURE 6 LABEL-FREE DETECTION MARKET: CAGR PROJECTIONS, 2023–2028
          FIGURE 7 LABEL-FREE DETECTION MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 
          FIGURE 8 DATA TRIANGULATION METHODOLOGY
    2.5 RESEARCH ASSUMPTIONS 
    2.6 RISK ANALYSIS 
    2.7 RECESSION IMPACT ANALYSIS 
          TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (%GROWTH)
          TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
          TABLE 3 US HEALTH EXPENDITURE, 2023–2030 (USD MILLION)
 
3 EXECUTIVE SUMMARY (Page No. - 48)
    FIGURE 9 LABEL-FREE DETECTION MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
    FIGURE 10 LABEL-FREE DETECTION MARKET, BY TECHNOLOGY,  2023 VS. 2028 (USD MILLION)
    FIGURE 11 LABEL-FREE DETECTION MARKET, BY APPLICATION,  2023 VS. 2028 (USD MILLION)
    FIGURE 12 LABEL-FREE DETECTION MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    FIGURE 13 GEOGRAPHICAL SNAPSHOT: LABEL-FREE DETECTION MARKET
 
4 PREMIUM INSIGHTS (Page No. - 52)
    4.1 LABEL-FREE DETECTION MARKET OVERVIEW 
          FIGURE 14 GROWING NUMBER OF DRUG DISCOVERY PROGRAMS TO DRIVE MARKET
    4.2 NORTH AMERICA: LABEL-FREE DETECTION MARKET SHARE,  BY PRODUCT & SERVICE AND COUNTRY (2022) 
          FIGURE 15 INSTRUMENTS DOMINATED NORTH AMERICAN LABEL-FREE DETECTION MARKET IN 2022
    4.3 ASIA PACIFIC: LABEL-FREE DETECTION MARKET,  BY END USER AND COUNTRY (2022) 
          FIGURE 16 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT ACCOUNTED FOR LARGEST SHARE OF APAC MARKET IN 2022
    4.4 LABEL-FREE DETECTION MARKET SHARE, BY END USER, 2022 
          FIGURE 17 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
    4.5 LABEL-FREE DETECTION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 
          FIGURE 18 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH RATE IN LABEL-FREE DETECTION MARKET FROM 2023 TO 2028
 
5 MARKET OVERVIEW (Page No. - 56)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 19 LABEL-FREE DETECTION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, CHALLENGES AND TRENDS
          TABLE 4 LABEL-FREE DETECTION MARKET: IMPACT ANALYSIS
           5.2.1 DRIVERS
                    5.2.1.1 Technological advancements in label-free detection
                    5.2.1.2 Growing academic-industrial partnerships for drug discovery programs
                    5.2.1.3 High sensitivity of label-free technologies
           5.2.2 RESTRAINTS
                    5.2.2.1 High cost of instruments
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growing life sciences research in emerging economies
           5.2.4 CHALLENGES
                    5.2.4.1 Sample complexity and interference
           5.2.5 TRENDS
                    5.2.5.1 Rising pharmaceutical outsourcing
                    5.2.5.2 Increasing applications of label-free electrochemical sensing platforms
    5.3 INDICATIVE PRICING ANALYSIS 
          TABLE 5 PRICING ANALYSIS FOR PRODUCTS
    5.4 VALUE CHAIN ANALYSIS 
          FIGURE 20 VALUE CHAIN ANALYSIS: MANUFACTURING PHASES ADD MAXIMUM VALUE
    5.5 ECOSYSTEM ANALYSIS 
          FIGURE 21 ECOSYSTEM ANALYSIS: LABEL-FREE DETECTION MARKET
          TABLE 6 OVERALL MARKET ECOSYSTEM: ROLE OF KEY PLAYERS AND ENTITIES
    5.6 PORTER’S FIVE FORCES ANALYSIS 
          TABLE 7 LABEL-FREE DETECTION MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.6.1 THREAT OF NEW ENTRANTS
           5.6.2 THREAT OF SUBSTITUTES
           5.6.3 BARGAINING POWER OF BUYERS
           5.6.4 BARGAINING POWER OF SUPPLIERS
           5.6.5 INTENSITY OF COMPETITIVE RIVALRY
    5.7 TECHNOLOGY ANALYSIS 
          TABLE 8 TECHNOLOGY ANALYSIS: BIOSENSOR ASSAYS VS. ISOTHERMAL TITRATION CALORIMETRY
    5.8 PATENT ANALYSIS 
          FIGURE 22 TOP PATENT OWNERS IN LABEL-FREE DETECTION, JANUARY 2013– JULY 2023
    5.9 REGULATORY SCENARIO ANALYSIS 
           5.9.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 9 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 10 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 11 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 12 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 13 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    5.10 KEY CONFERENCES AND EVENTS IN 2023–2024 
          TABLE 14 LABEL-FREE DETECTION MARKET: LIST OF CONFERENCES AND EVENTS
    5.11 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF LABEL-FREE DETECTION TECHNOLOGIES
           5.11.2 BUYING CRITERIA FOR LABEL-FREE DETECTION PRODUCTS
                     FIGURE 24 KEY BUYING CRITERIA FOR END USERS
 
6 LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE (Page No. - 74)
    6.1 INTRODUCTION 
          TABLE 15 LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
    6.2 INSTRUMENTS 
           6.2.1 TECHNOLOGICAL ADVANCEMENTS IN LABEL-FREE DETECTION SYSTEMS TO DRIVE INSTRUMENTS MARKET
                    TABLE 16 LABEL-FREE DETECTION INSTRUMENTS OFFERED, BY COMPANY
                    TABLE 17 LABEL-FREE DETECTION INSTRUMENTS MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 18 NORTH AMERICA: LABEL-FREE DETECTION INSTRUMENTS MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 19 EUROPE: LABEL-FREE DETECTION INSTRUMENTS MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 20 ASIA PACIFIC: LABEL-FREE DETECTION INSTRUMENTS MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
    6.3 CONSUMABLES 
          TABLE 21 LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 22 LABEL-FREE DETECTION CONSUMABLES MARKET, BY REGION,  2021–2028 (USD MILLION)
          TABLE 23 NORTH AMERICA: LABEL-FREE DETECTION CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 24 EUROPE: LABEL-FREE DETECTION CONSUMABLES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
          TABLE 25 ASIA PACIFIC: LABEL-FREE DETECTION CONSUMABLES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
           6.3.1 BIOSENSOR CHIPS
                    6.3.1.1 High specificity and real-time monitoring to boost demand
                                TABLE 26 BIOSENSOR CHIPS OFFERED, BY COMPANY
                                TABLE 27 BIOSENSOR CHIPS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 28 NORTH AMERICA: BIOSENSOR CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 29 EUROPE: BIOSENSOR CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 30 ASIA PACIFIC: BIOSENSOR CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.2 MICROPLATES
                    6.3.2.1 Low cost and wide usage to drive market
                                TABLE 31 MICROPLATES OFFERED, BY COMPANY
                                TABLE 32 MICROPLATES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 33 NORTH AMERICA: MICROPLATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 34 EUROPE: MICROPLATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 35 ASIA PACIFIC: MICROPLATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.3 REAGENTS & KITS
                    6.3.3.1 Availability of ready-to-use kits for assay development to drive market
                                TABLE 36 REAGENTS & KITS OFFERED, BY COMPANY
                                TABLE 37 REAGENTS & KITS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 38 NORTH AMERICA: REAGENTS & KITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 39 EUROPE: REAGENTS & KITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 40 ASIA PACIFIC: REAGENTS & KITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    6.4 SOFTWARE & SERVICES 
           6.4.1 AUTOMATION IN LABEL-FREE DETECTION TO DRIVE DEMAND
                    TABLE 41 SOFTWARE & SERVICES OFFERED, BY COMPANY
                    TABLE 42 LABEL-FREE DETECTION SOFTWARE & SERVICES MARKET, BY REGION,  2021–2028 (USD MILLION)
                    TABLE 43 NORTH AMERICA: LABEL-FREE DETECTION SOFTWARE & SERVICES MARKET,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 44 EUROPE: LABEL-FREE DETECTION SOFTWARE & SERVICES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 45 ASIA PACIFIC: LABEL-FREE DETECTION SOFTWARE & SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
 
7 LABEL-FREE DETECTION MARKET, BY TECHNOLOGY (Page No. - 93)
    7.1 INTRODUCTION 
          TABLE 46 LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
    7.2 SURFACE PLASMON RESONANCE 
           7.2.1 GROWING USE OF SPR TECHNOLOGY IN AFFINITY AND KINETIC STUDIES TO FUEL MARKET GROWTH
                    TABLE 47 LABEL-FREE DETECTION MARKET FOR SURFACE PLASMON RESONANCE, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 48 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 49 EUROPE: LABEL-FREE DETECTION MARKET FOR SURFACE PLASMON RESONANCE,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 50 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2021–2028 (USD MILLION)
    7.3 DIFFERENTIAL SCANNING CALORIMETRY 
           7.3.1 WIDE USAGE IN DRUG DISCOVERY AND DEVELOPMENT
                    TABLE 51 LABEL-FREE DETECTION MARKET FOR DIFFERENTIAL SCANNING CALORIMETRY,  BY REGION, 2021–2028 (USD MILLION)
                    TABLE 52 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR DIFFERENTIAL SCANNING CALORIMETRY, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 53 EUROPE: LABEL-FREE DETECTION MARKET FOR DIFFERENTIAL SCANNING CALORIMETRY, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 54 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR DIFFERENTIAL SCANNING CALORIMETRY, BY COUNTRY, 2021–2028 (USD MILLION)
    7.4 BIO-LAYER INTERFEROMETRY 
           7.4.1 MICROFLUIDICS-FREE CHARACTERISTIC TO BOOST ADOPTION
                    TABLE 55 LABEL-FREE DETECTION MARKET FOR BIO-LAYER INTERFEROMETRY, BY REGION,  2021–2028 (USD MILLION)
                    TABLE 56 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR BIO-LAYER INTERFEROMETRY, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 57 EUROPE: LABEL-FREE DETECTION MARKET FOR BIO-LAYER INTERFEROMETRY,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 58 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR BIO-LAYER INTERFEROMETRY,  BY COUNTRY, 2021–2028 (USD MILLION)
    7.5 ISOTHERMAL TITRATION CALORIMETRY 
           7.5.1 SUPPORT FOR BETTER HIT SELECTION AND LEAD OPTIMIZATION TO DRIVE ADOPTION
                    TABLE 59 LABEL-FREE DETECTION MARKET FOR ISOTHERMAL TITRATION CALORIMETRY,  BY REGION, 2021–2028 (USD MILLION)
                    TABLE 60 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR ISOTHERMAL TITRATION CALORIMETRY, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 61 EUROPE: LABEL-FREE DETECTION MARKET FOR ISOTHERMAL TITRATION CALORIMETRY, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 62 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR ISOTHERMAL TITRATION CALORIMETRY, BY COUNTRY, 2021–2028 (USD MILLION)
    7.6 OTHER TECHNOLOGIES 
          TABLE 63 LABEL-FREE DETECTION MARKET FOR OTHER TECHNOLOGIES, BY REGION,  2021–2028 (USD MILLION)
          TABLE 64 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR OTHER TECHNOLOGIES,  BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 65 EUROPE: LABEL-FREE DETECTION MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 66 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR OTHER TECHNOLOGIES,  BY COUNTRY, 2021–2028 (USD MILLION)
 
8 LABEL-FREE DETECTION MARKET, BY APPLICATION (Page No. - 105)
    8.1 INTRODUCTION 
          TABLE 67 LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
    8.2 BINDING KINETICS 
           8.2.1 BINDING KINETICS TO HOLD LARGEST MARKET SHARE TILL 2028
                    TABLE 68 LABEL-FREE DETECTION MARKET FOR BINDING KINETICS, BY REGION,  2021–2028 (USD MILLION)
                    TABLE 69 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR BINDING KINETICS,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 70 EUROPE: LABEL-FREE DETECTION MARKET FOR BINDING KINETICS, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 71 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR BINDING KINETICS, BY COUNTRY, 2021–2028 (USD MILLION)
    8.3 BINDING THERMODYNAMICS 
           8.3.1 WIDE APPLICATIONS IN BASIC RESEARCH TO DRIVE MARKET
                    TABLE 72 LABEL-FREE DETECTION MARKET FOR BINDING THERMODYNAMICS, BY REGION,  2021–2028 (USD MILLION)
                    TABLE 73 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR BINDING THERMODYNAMICS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 74 EUROPE: LABEL-FREE DETECTION MARKET FOR BINDING THERMODYNAMICS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 75 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR BINDING THERMODYNAMICS,  BY COUNTRY, 2021–2028 (USD MILLION)
    8.4 HIT CONFIRMATION 
           8.4.1 NEED TO STUDY BIOMOLECULAR INTERACTIONS IN NATIVE STATES TO BOOST USAGE
                    TABLE 76 LABEL-FREE DETECTION MARKET FOR HIT CONFIRMATION, BY REGION,  2021–2028 (USD MILLION)
                    TABLE 77 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR HIT CONFIRMATION,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 78 EUROPE: LABEL-FREE DETECTION MARKET FOR HIT CONFIRMATION, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 79 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR HIT CONFIRMATION, BY COUNTRY, 2021–2028 (USD MILLION)
    8.5 LEAD GENERATION 
           8.5.1 TECHNOLOGICAL ADVANCEMENTS TO DRIVE APPLICATIONS IN DRUG CANDIDATE SELECTION
                    TABLE 80 LABEL-FREE DETECTION MARKET FOR LEAD GENERATION, BY REGION,  2021–2028 (USD MILLION)
                    TABLE 81 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR LEAD GENERATION,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 82 EUROPE: LABEL-FREE DETECTION MARKET FOR LEAD GENERATION, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 83 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR LEAD GENERATION, BY COUNTRY, 2021–2028 (USD MILLION)
    8.6 ENDOGENOUS RECEPTOR DETECTION 
           8.6.1 HIGH SENSITIVITY OF LABEL-FREE ASSAYS TO DRIVE ADOPTION
                    TABLE 84 LABEL-FREE DETECTION MARKET FOR ENDOGENOUS RECEPTOR DETECTION, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 85 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR ENDOGENOUS RECEPTOR DETECTION, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 86 EUROPE: LABEL-FREE DETECTION MARKET FOR ENDOGENOUS RECEPTOR DETECTION,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 87 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR ENDOGENOUS RECEPTOR DETECTION, 2021–2028 (USD MILLION)
    8.7 OTHER APPLICATIONS 
          TABLE 88 LABEL-FREE DETECTION MARKET FOR OTHER APPLICATIONS, BY REGION,  2021–2028 (USD MILLION)
          TABLE 89 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR OTHER APPLICATIONS,  BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 90 EUROPE: LABEL-FREE DETECTION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 91 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR OTHER APPLICATIONS,  2021–2028 (USD MILLION)
 
9 LABEL-FREE DETECTION MARKET, BY END USER (Page No. - 119)
    9.1 INTRODUCTION 
          TABLE 92 LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION)
    9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 
           9.2.1 PHARMA & BIOTECH COMPANIES TO HOLD LARGEST MARKET SHARE TILL 2028
                    TABLE 93 LABEL-FREE DETECTION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 94 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 95 EUROPE: LABEL-FREE DETECTION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 96 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
    9.3 ACADEMIC & RESEARCH INSTITUTES 
           9.3.1 RISING INDUSTRY-ACADEMIA RESEARCH COLLABORATIONS TO DRIVE MARKET
                    TABLE 97 LABEL-FREE DETECTION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 98 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 99 EUROPE: LABEL-FREE DETECTION MARKET FOR ACADEMIC & RESEARCH INSTITUTES,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 100 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
    9.4 CONTRACT RESEARCH ORGANIZATIONS 
           9.4.1 INCREASING PHARMACEUTICAL OUTSOURCING TO DRIVE MARKET GROWTH
                    TABLE 101 LABEL-FREE DETECTION MARKET FOR CROS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 102 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR CROS, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 103 EUROPE: LABEL-FREE DETECTION MARKET FOR CROS, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 104 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR CROS, BY COUNTRY,  2021–2028 (USD MILLION)
    9.5 OTHER END USERS 
          TABLE 105 LABEL-FREE DETECTION MARKET FOR OTHER END USERS, BY REGION,  2021–2028 (USD MILLION)
          TABLE 106 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR OTHER END USERS,  BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 107 EUROPE: LABEL-FREE DETECTION MARKET FOR OTHER END USERS, BY COUNTRY,  2021–2028 (USD MILLION)
          TABLE 108 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
 
10 LABEL-FREE DETECTION MARKET, BY REGION (Page No. - 129)
     10.1 INTRODUCTION 
             TABLE 109 LABEL-FREE DETECTION MARKET, BY REGION, 2021–2028 (USD MILLION)
     10.2 NORTH AMERICA 
             10.2.1 NORTH AMERICA: RECESSION IMPACT
                        FIGURE 25 NORTH AMERICA: LABEL-FREE DETECTION MARKET SNAPSHOT
                        TABLE 110 NORTH AMERICA: LABEL-FREE DETECTION MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                        TABLE 111 NORTH AMERICA: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                        TABLE 112 NORTH AMERICA: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 113 NORTH AMERICA: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)
                        TABLE 114 NORTH AMERICA: LABEL-FREE DETECTION MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
                        TABLE 115 NORTH AMERICA: LABEL-FREE DETECTION MARKET, BY END USER,  2021–2028 (USD MILLION)
             10.2.2 US
                        10.2.2.1 US to dominate label-free detection market in North America
                                      TABLE 116 US: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                                      TABLE 117 US: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 118 US: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 119 US: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 120 US: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.2.3 CANADA
                        10.2.3.1 Government initiatives to promote research to support market growth
                                      TABLE 121 CANADA: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                                      TABLE 122 CANADA: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 123 CANADA: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)
                                      TABLE 124 CANADA: LABEL-FREE DETECTION MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
                                      TABLE 125 CANADA: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION)
     10.3 EUROPE 
             10.3.1 EUROPE: RECESSION IMPACT
                        TABLE 126 EUROPE: LABEL-FREE DETECTION MARKET BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 127 EUROPE: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                        TABLE 128 EUROPE: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 129 EUROPE: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                        TABLE 130 EUROPE: LABEL-FREE DETECTION MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
                        TABLE 131 EUROPE: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.2 GERMANY
                        10.3.2.1 Germany to dominate European label-free detection market
                                      TABLE 132 GERMANY: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                                      TABLE 133 GERMANY: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 134 GERMANY: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)
                                      TABLE 135 GERMANY: LABEL-FREE DETECTION MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
                                      TABLE 136 GERMANY: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.3 UK
                        10.3.3.1 Government and private sponsorships for drug discovery services to support market
                                      TABLE 137 UK: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                                      TABLE 138 UK: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 139 UK: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 140 UK: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 141 UK: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.4 FRANCE
                        10.3.4.1 Favorable funding scenario to drive market
                                      TABLE 142 FRANCE: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                                      TABLE 143 FRANCE: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 144 FRANCE: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)
                                      TABLE 145 FRANCE: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 146 FRANCE: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.5 ITALY
                        10.3.5.1 Rising life science R&D to drive market
                                      TABLE 147 ITALY: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                                      TABLE 148 ITALY: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 149 ITALY: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 150 ITALY: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 151 ITALY: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.6 SPAIN
                        10.3.6.1 Increasing focus on personalized medicines to drive market
                                      TABLE 152 SPAIN: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                                      TABLE 153 SPAIN: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 154 SPAIN: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 155 SPAIN: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 156 SPAIN: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.7 REST OF EUROPE
                        TABLE 157 REST OF EUROPE: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                        TABLE 158 REST OF EUROPE: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 159 REST OF EUROPE: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)
                        TABLE 160 REST OF EUROPE: LABEL-FREE DETECTION MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
                        TABLE 161 REST OF EUROPE: LABEL-FREE DETECTION MARKET, BY END USER,  2021–2028 (USD MILLION)
     10.4 ASIA PACIFIC 
             10.4.1 ASIA PACIFIC: RECESSION IMPACT
                        TABLE 162 ASIA PACIFIC: LABEL-FREE DETECTION MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                        TABLE 163 ASIA PACIFIC: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                        TABLE 164 ASIA PACIFIC: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 165 ASIA PACIFIC: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)
                        TABLE 166 ASIA PACIFIC: LABEL-FREE DETECTION MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
                        TABLE 167 ASIA PACIFIC: LABEL-FREE DETECTION MARKET, BY END USER,  2021–2028 (USD MILLION)
             10.4.2 CHINA
                        10.4.2.1 China to dominate APAC label-free detection market
                                      TABLE 168 CHINA: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                                      TABLE 169 CHINA: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 170 CHINA: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 171 CHINA: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 172 CHINA: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.4.3 JAPAN
                        10.4.3.1 Robust funding for research to propel market growth
                                      TABLE 173 JAPAN: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                                      TABLE 174 JAPAN: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 175 JAPAN: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 176 JAPAN: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 177 JAPAN: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.4.4 INDIA
                        10.4.4.1 Growing R&D spending by pharma companies and favorable government initiatives to support adoption
                                      TABLE 178 INDIA: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                                      TABLE 179 INDIA: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 180 INDIA: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 181 INDIA: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 182 INDIA: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.4.5 REST OF ASIA PACIFIC
                        TABLE 183 REST OF ASIA PACIFIC: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                        TABLE 184 REST OF ASIA PACIFIC: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 185 REST OF ASIA PACIFIC: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)
                        TABLE 186 REST OF ASIA PACIFIC: LABEL-FREE DETECTION MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
                        TABLE 187 REST OF ASIA PACIFIC: LABEL-FREE DETECTION MARKET, BY END USER,  2021–2028 (USD MILLION)
     10.5 LATIN AMERICA 
             10.5.1 RISING ADOPTION OF LABEL-FREE DETECTION TECHNOLOGIES IN BIOTECH & PHARMA SECTORS TO SUPPORT GROWTH
             10.5.2 LATIN AMERICA: RECESSION IMPACT
                        TABLE 188 LATIN AMERICA: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                        TABLE 189 LATIN AMERICA: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 190 LATIN AMERICA: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)
                        TABLE 191 LATIN AMERICA: LABEL-FREE DETECTION MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
                        TABLE 192 LATIN AMERICA: LABEL-FREE DETECTION MARKET, BY END USER,  2021–2028 (USD MILLION)
     10.6 MIDDLE EAST & AFRICA 
             10.6.1 GROWING PHARMACEUTICAL INDUSTRY TO DRIVE MARKET
             10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
                        TABLE 193 MIDDLE EAST & AFRICA: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                        TABLE 194 MIDDLE EAST & AFRICA: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 195 MIDDLE EAST & AFRICA: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                        TABLE 196 MIDDLE EAST & AFRICA: LABEL-FREE DETECTION MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
                        TABLE 197 MIDDLE EAST & AFRICA: LABEL-FREE DETECTION MARKET, BY END USER,  2021–2028 (USD MILLION)
 
11 COMPETITIVE LANDSCAPE (Page No. - 181)
     11.1 INTRODUCTION 
     11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS 
             FIGURE 26 LABEL-FREE DETECTION MARKET: STRATEGIES ADOPTED BY KEY PLAYERS, 2020-2023
     11.3 MARKET SHARE ANALYSIS 
             FIGURE 27 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2022
             TABLE 198 LABEL-FREE DETECTION MARKET: DEGREE OF COMPETITION
     11.4 REVENUE SHARE ANALYSIS 
             FIGURE 28 REVENUE ANALYSIS OF KEY PLAYERS, 2020–2022
     11.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022 
             FIGURE 29 LABEL-FREE DETECTION MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022
             11.5.1 STARS
             11.5.2 EMERGING LEADERS
             11.5.3 PERVASIVE PLAYERS
             11.5.4 PARTICIPANTS
     11.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS 
             11.6.1 COMPANY PRODUCT FOOTPRINT (25 COMPANIES)
                        TABLE 199 PRODUCT FOOTPRINT ANALYSIS
             11.6.2 COMPANY REGIONAL FOOTPRINT (25 COMPANIES)
                        TABLE 200 REGIONAL FOOTPRINT ANALYSIS
     11.7 COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022 
             FIGURE 30 LABEL-FREE DETECTION MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
             11.7.1 PROGRESSIVE COMPANIES
             11.7.2 RESPONSIVE COMPANIES
             11.7.3 DYNAMIC COMPANIES
             11.7.4 STARTING BLOCKS
     11.8 COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS 
             TABLE 201 LABEL-FREE DETECTION MARKET: DETAILED LIST OF KEY START-UP/SME PLAYERS
             TABLE 202 LABEL-FREE DETECTION MARKET: COMPETITIVE BENCHMARKING OF  START-UP/SME PLAYERS
     11.9 COMPETITIVE SCENARIO AND TRENDS 
             11.9.1 PRODUCT LAUNCHES
                        TABLE 203 LABEL-FREE DETECTION MARKET: PRODUCT LAUNCHES,  JANUARY 2020–JUNE 2023
             11.9.2 DEALS
                        TABLE 204 LABEL-FREE DETECTION MARKET: DEALS, JANUARY 2020–JUNE 2023
             11.9.3 OTHER DEVELOPMENTS
                        TABLE 205 LABEL-FREE DETECTION MARKET: OTHER DEVELOPMENTS,  JANUARY 2020–JUNE 2023
 
12 COMPANY PROFILES (Page No. - 196)
     12.1 KEY PLAYERS 
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
             12.1.1 DANAHER
                        TABLE 206 DANAHER: BUSINESS OVERVIEW
                        FIGURE 31 DANAHER: COMPANY SNAPSHOT (2022)
             12.1.2 SARTORIUS AG
                        TABLE 207 SARTORIUS AG: BUSINESS OVERVIEW
                        FIGURE 32 SARTORIUS AG: COMPANY SNAPSHOT (2022)
             12.1.3 WATERS CORPORATION
                        TABLE 208 WATERS CORPORATION: BUSINESS OVERVIEW
                        FIGURE 33 WATERS: COMPANY SNAPSHOT (2022)
             12.1.4 PERKINELMER, INC.
                        TABLE 209 PERKINELMER, INC.: BUSINESS OVERVIEW
                        FIGURE 34 PERKINELMER, INC.: COMPANY SNAPSHOT (2022)
             12.1.5 AMETEK, INC.
                        TABLE 210 AMETEK, INC.: BUSINESS OVERVIEW
                        FIGURE 35 AMETEK, INC.: COMPANY SNAPSHOT (2022)
             12.1.6 HORIBA, LTD.
                        TABLE 211 HORIBA, LTD.: BUSINESS OVERVIEW
                        FIGURE 36 HORIBA, LTD.: COMPANY SNAPSHOT (2022)
             12.1.7 SPECTRIS
                        TABLE 212 SPECTRIS: BUSINESS OVERVIEW
                        FIGURE 37 SPECTRIS: COMPANY SNAPSHOT
             12.1.8 METTLER TOLEDO INTERNATIONAL, INC.
                        TABLE 213 METTLER TOLEDO INTERNATIONAL, INC.: BUSINESS OVERVIEW
                        FIGURE 38 METTLER TOLEDO INTERNATIONAL, INC.: COMPANY SNAPSHOT (2022)
             12.1.9 AGILENT TECHNOLOGIES, INC.
                        TABLE 214 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
                        FIGURE 39 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022)
             12.1.10 SHIMADZU CORPORATION
                        TABLE 215 SHIMADZU CORPORATION: BUSINESS OVERVIEW
                        FIGURE 40 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2022)
             12.1.11 HITACHI HIGH-TECH CORPORATION
                        TABLE 216 HITACHI HIGH-TECH CORPORATION: BUSINESS OVERVIEW
                        FIGURE 41 HITACHI HIGH-TECH CORPORATION: COMPANY SNAPSHOT (2022)
             12.1.12 ATTANA AB
                        TABLE 217 ATTANA AB: BUSINESS OVERVIEW
                        FIGURE 42 ATTANA AB: COMPANY SNAPSHOT (2022)
             12.1.13 BRUKER
                        TABLE 218 BRUKER: BUSINESS OVERVIEW
                        FIGURE 43 BRUKER: COMPANY SNAPSHOT (2022)
     12.2 OTHER PLAYERS 
             12.2.1 NANOTEMPER TECHNOLOGIES GMBH
             12.2.2 AFFINITÉ INSTRUMENTS
             12.2.3 BIOSENSING INSTRUMENT
             12.2.4 UNCHAINED LABS
             12.2.5 BIONAVIS LTD.
             12.2.6 CARTERRA, INC.
             12.2.7 NICOYA
             12.2.8 BIOPTIX ANALYTICAL LLC
             12.2.9 PLEXERA BIOSCIENCE
             12.2.10 XANTEC BIOANALYTICS GMBH
             12.2.11 LINO BIOTECH AG (MILTENYI BIOTEC)
             12.2.12 KEP TECHNOLOGIES
 
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
 
13 APPENDIX (Page No. - 252)
     13.1 DISCUSSION GUIDE 
     13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’  SUBSCRIPTION PORTAL 
     13.3 CUSTOMIZATION OPTIONS 
     13.4 RELATED REPORTS 
     13.5 AUTHOR DETAILS 

This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global label-free detection market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

The secondary sources referred to for this research study include publications from government sources, such as World Health Organization (WHO), the National Center for Biotechnology Information (NCBI), the National Institutes of Health (NIH), the US Food and Drug Administration (US FDA), the International Molecular Exchange Consortium (IMEx), the Biomolecular Interaction Network Database (BIND), the European Federation of Pharmaceutical Industries and Associations (EFPIA), the European Lead Factory (ELF), India Brand Equity Foundation (IBEF), the UK Research Partnership Investment Fund (UKRPIF), and Pharmaceutical Research and Manufacturers of America (PhRMA). Secondary sources also include corporate and regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global label-free detection market, which was validated through primary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global label-free detection market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as personnel from pharmaceutical and biopharmaceutical industries, CMOs and CROs, academic & research institutes, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. These interviews were conducted across four major regions, including the Asia Pacific, North America, Europe, Latin America, and the Middle East & Africa. Approximately 80% and 20% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

The following is a breakdown of the primary respondents:

Label-Free Detection Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The global size of the market was estimated through multiple approaches. A detailed market estimation approach was followed to estimate and validate the value of the label-free detection market and other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and market have been identified through extensive primary and secondary research.
  • The revenues generated from the label-free detection business of leading players have been determined through primary and secondary research.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Global Label-free Detection Market: Bottom-Up Approach

Label-Free Detection Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Global Label-free Detection Market: Top Down Approach

Label-Free Detection Market Size, and Share

Data Triangulation

After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Market Definition

Label-free detection is gaining widespread acceptance as an important research and development tool in academic research institutes and biotechnology and pharmaceutical industries. It helps in the investigation of molecule-molecule interactions without using additional isotope or fluorescent labels that usually cause spatial interference or quenching.

Key Stakeholders

  • Pharmaceutical and biotechnology research associations
  • Label-free equipment manufacturers and vendors
  • Research and consulting firms
  • Pathologists and pathology laboratories
  • Distributors of label-free detection equipment
  • Research institutes
  • Contract research organizations (CROs)
  • Venture capitalists
  • Government associations

Report Objectives

  • To define, describe, and forecast the global Label-free detection market based on product & service, technology, application, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile the key players and comprehensively analyze their product & service portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and collaborations in the market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Geographical Analysis

  • Further breakdown of the Rest of Europe label-free detection market, by country
  • Further breakdown of the Rest of Asia Pacific label-free detection market, by country
  • Further breakdown of the Latin America and Middle East & Africa label-free detection market, by country

Company Information

  • Detailed analysis and profiling of additional market players (up to five)

Segment Analysis

  • Further breakdown of the disease indication area segment as per the service portfolio of prominent players operating in the market.
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
BT 2455
Published ON
Jul, 2023
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Label Free Detection Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2023 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback